TWD 33.45
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 3.62 Billion TWD | -20.34% |
2022 | 4.55 Billion TWD | 7.87% |
2021 | 4.22 Billion TWD | -4.55% |
2020 | 4.42 Billion TWD | 12.91% |
2019 | 3.91 Billion TWD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 3.85 Billion TWD | -2.47% |
2024 Q1 | 3.95 Billion TWD | 8.89% |
2023 Q3 | 3.64 Billion TWD | -26.27% |
2023 Q2 | 4.94 Billion TWD | 1.56% |
2023 FY | 3.62 Billion TWD | -20.34% |
2023 Q1 | 4.87 Billion TWD | 0.0% |
2023 Q4 | 3.62 Billion TWD | -0.53% |
2022 Q4 | - TWD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Allied Biotech Corporation | 910.11 Million TWD | -298.596% |
GeneFerm Biotechnology Co., Ltd. | 282.53 Million TWD | -1183.963% |
Easywell Biomedicals, Inc. | 589.98 Million TWD | -514.874% |
TTY Biopharm Company Limited | 3.36 Billion TWD | -7.686% |
Orient EuroPharma Co., Ltd. | 6.64 Billion TWD | 45.443% |
Center Laboratories, Inc. | 6.78 Billion TWD | 46.541% |
Tien Liang BioTech Co., Ltd. | 161.05 Million TWD | -2152.491% |
Orient Pharma Co., Ltd. | 892.18 Million TWD | -306.608% |
InnoPharmax Inc. | 48.64 Million TWD | -7356.848% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 320.99 Million TWD | -1030.144% |
Excelsior Biopharma Inc. | 472.87 Million TWD | -667.156% |
DV Biomed Co., Ltd. | 765.87 Million TWD | -373.666% |
Foresee Pharmaceuticals Co., Ltd. | 616.93 Million TWD | -488.02% |
Handa Pharmaceuticals, Inc. | 280.88 Million TWD | -1191.537% |
UniPharma Co., Ltd. | 37.4 Million TWD | -9599.425% |
Anxo Pharmaceutical Co., Ltd. | 1.01 Billion TWD | -257.291% |
Alar Pharmaceuticals Inc. | 76.08 Million TWD | -4667.683% |
Winston Medical Supply Co., Ltd. | 373.87 Million TWD | -870.293% |
Mercury Biopharmaceutical Corporation | 49.72 Million TWD | -7196.076% |
Bioray Biotech Co., Ltd | 108.75 Million TWD | -3235.738% |
TSH Biopharm Corporation Limited | 133.62 Million TWD | -2614.803% |